Nature's Sunshine To Gain From Margin Expansion - Analyst Projects 15% Adjusted EBITDA Margin By FY28
Portfolio Pulse from Nabaparna Bhattacharya
Canaccord Genuity analyst Susan Anderson initiated coverage on Nature’s Sunshine Products (NASDAQ:NATR) with a Buy rating and a price target of $18. The company is expected to achieve a 15% adjusted EBITDA margin by FY28 through digital sector investments, international expansion, and product innovation. NATR shares rose 6.26% to $14.08.
September 13, 2024 | 6:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nature's Sunshine Products received a Buy rating from Canaccord Genuity with a price target of $18. The company is expected to achieve a 15% adjusted EBITDA margin by FY28 through strategic investments and expansion. Shares rose 6.26% to $14.08.
The analyst's Buy rating and positive outlook on margin expansion and strategic growth initiatives are likely to boost investor confidence, contributing to the stock's recent price increase. The projected margin improvement and strategic focus on digital and international markets are key factors for potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100